Evidence map›Paper›PMID 33497363›Full record

ArticleJCI insight2021

Particulate matter causes skin barrier dysfunction.

Byung Eui Kim, Jihyun Kim, Elena Goleva, Evgeny Berdyshev, Jinyoung Lee, Kathryn A Vang, Un Ha Lee, SongYi Han, Susan Leung, Clifton F Hall and 6 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Low Humidity Alters Epidermal Gene Expression in vivo.Clinical, cosmetic and investigational dermatology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Byung Eui KimDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Jihyun KimDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Elena GolevaDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Evgeny BerdyshevDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Jinyoung LeeEnvironmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, South Korea.
Kathryn A VangDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Un Ha LeeDepartment of Dermatology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea.
SongYi HanEnvironmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, South Korea.
Susan LeungDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Clifton F HallDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Na-Rae KimEnvironmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, South Korea.
Irina BronovaDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Eu Jin LeeEnvironmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, South Korea.
Hye-Ran YangSeoul Metropolitan Government Research Institute of Public Health and Environment, Seoul, South Korea.
Donald Ym LeungDepartment of Pediatrics, National Jewish Health, Denver, Colorado, USA.
Kangmo AhnDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
National Jewish Health · USSamsung Medical Center · KRInje University Sanggye Paik Hospital · KRSeoul Metropolitan Government · KR

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTERU01AI152037 · NIAID · NATIONAL JEWISH HEALTH · PI Elena Goleva, Donald YM Leung · 2020 to 2026
$2.3M
NCATS NIH HHS UL1 TR002535NIAID NIH HHS U01 AI152037
6 · The paper itself

Abstract

The molecular mechanisms that underlie the detrimental effects of particulate matter (PM) on skin barrier function are poorly understood. In this study, the effects of PM2.5 on filaggrin (FLG) and skin barrier function were investigated in vitro and in vivo. The levels of FLG degradation products, including pyrrolidone carboxylic acid, urocanic acid (UCA), and cis/trans-UCA, were significantly decreased in skin tape stripping samples of study subjects when they moved from Denver, an area with low PM2.5, to Seoul, an area with high PM2.5 count. Experimentally, PM2.5 collected in Seoul inhibited FLG, loricrin, keratin-1, desmocollin-1, and corneodesmosin but did not modulate involucrin or claudin-1 in keratinocyte cultures. Moreover, FLG protein expression was inhibited in human skin equivalents and murine skin treated with PM2.5. We demonstrate that this process was mediated by PM2.5-induced TNF-α and was aryl hydrocarbon receptor dependent. PM2.5 exposure compromised skin barrier function, resulting in increased transepidermal water loss, and enhanced the penetration of FITC-dextran in organotypic and mouse skin. PM2.5-induced TNF-α caused FLG deficiency in the skin and subsequently induced skin barrier dysfunction. Compromised skin barrier due to PM2.5 exposure may contribute to the development and the exacerbation of allergic diseases such as atopic dermatitis.

Indexed as

AdultAnimalsDermatitis, AtopicFemaleFilaggrin ProteinsHumansMaleMiceNIH 3T3 CellsParticulate MatterSkinFilaggrin ProteinsParticulate MatterDermatologyInflammationMouse modelsSkin

Identifiers

PMID33497363
PMCPMC8021104
OpenAlexW3125398380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.